Transcription Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is a gene?

A

basic unit of hereditary and a sequence of nucleotides in DNA that encodes for the synthesis of a gene -> protein product.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Process and role of transcription

A

role of transcription is to convert DNA to RNA to make a protein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Initiation Transcription

A

Promotor region: TATA, CAAT, GC

RNA polymerase 2 and GTFs will bind at the promotor site to start transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

RNA polymerase requires several general TFs to start transcription:

A
  1. TFIID binds the (promotor site) TATA box, through the TBP subunit
    -> this enables binding of TFIIB
  2. The rest of general TFs (TFIIE, TFIIH) and RNA polymerase II assemble at the promoter
  3. TFIIH contains a DNA helicase as one of its subunits and can use the energy from ATP hydrolysis to separate DNA double helix at the transcription start point, exposing the template strand.
  4. TFIIH also phosphorylates RNA pol II, changing its shape
    -> in RNA pol II being released from the TFs and starting the elongation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In addition to the promotor needing the 5TFs and RNAP 2, transcription needs regulatory proteins:

A
  1. Mediator proteins: large protein complex
  2. Transcription activator proteins: bind to enhancers to attract RNA2, TFs, promotor, and mediator. -> they also attract ATP dependant chromatin modelling complexes and histone modifying enzymes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Elongation

A

RNA Polymerase reads the template:

  1. Reads the DNA in the 3’ to 5’ end. (Template strand)
  2. Synthesizes RNA in the 5’ to 3’ end.

The RNA transcript is nearly identical to the non-template, or coding, strand of DNA. However, RNA strands have the base uracil (U) in place of thymine (T), as well as a slightly different sugar in the nucleotide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Amastin

A

toxin component of mushrooms which can inhibit RNA polymerases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rifampin

A

antibiotic that can inhibit the RNA in prokaryotic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Termination:

A

Sequence dependant termination of the RNA growth chain

hits a terminator sequence AA U AAA
a polyadenylation signal
activates enzymes cleaving RNA

RNA polymerase will keep transcribing until it gets signals to stop. The process of ending transcription is called termination, and it happens once the polymerase transcribes a sequence of DNA known as a terminator.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does RNA polymerase differ to DNA polymerase?

A

RNA polymerases catalyse the linkage of ribonucleotides
RNA polymerases can start an RNA chain without a primer
RNA polymerases are absolutely processive – the same RNA polymerase starts and finishes an RNA mole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Post Transcriptional Processes that transform pre-RNA to Mature mRNA

A

Capping
Tailing
Splicing

The processing of mRNA involves modification of the 5’ terminus by capping with 7-methlyguanosine (m7G), modification of the 3’ terminus by polyadenylation, and removal of introns by splicing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CAPPING

A

When RNA polymerase 2 has made a nucleotide sequence of RNA, the 5’ end is modified by the addition of a cap consisting of m7G

Capping is initiated by the addition of guanosine triphate (GTP) in reverse linkage of the terminal nucleotide of the RNA

Then methyl groups are added to the G residue and the ribose moieties of one or two 5’nucelosides of the RNA chain.

The 5’ cap protects the new mRNA from degrading and assists ribosome binding during translation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

POLYDEYLATION

A

The 3’ end is not defined by termination of transcription but by the cleavage of the primary transcript and addition of a POLY-A tail -> polyadenylation

The POLYA tail:
protects from degrading
aids export o mature mRNA to cytoplasm
involved in binding proteins to initiate translation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SPLICING

A

Introns removed and exons are spliced together -> this takes place at complexes called spliceosomes.

Cleavage at the 5’ splice site: formation of a lariat like intermediate
Cleavage at the 3’ splice site: ligation of exons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why splice?

A

New transcripts are spliced in more than 1 way (alternative splicing)

Increases diversity of proteins that can be encoded by the 20,000 genes.

RNA splicing enables eukaryotes to increase the coding potential of their genomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

mRNA Transport:

A

mRNA is synthesised in the nucleus and needs to go to the cytosol for translation.

Only can be transported once the proteins present on the mRNA molecule collectively signify that processing was successfully completed.

The mRNA is then guided via nuclear pore complexes in the nuclear membrane which connects the nucleoplasm and cytosol

17
Q

β thalassemia and transcription

A

Abnormal processing of the β-globin

primary RNA transcript in humans with the β thalassemia

The disease (severe anaemia due to aberrant haemoglobin synthesis) is caused by splice-site mutations found in the genomes of affected patients

18
Q

Phenylketonuria (PKU)

A

A single base mutation
156bp deletion in the mRNA, corresponding precisely to the length of Exon 12 that leads to a truncated PAH (phenylalanine hydroxylase) protein that is unstable with almost zero PAH activity

19
Q

Tamoxifen

A

selective oestrogen receptor modulator (SERM) medication used to treat breast cancer in men and women and as a prophylactic agent against breast cancer in women.

Reduces the risk of breast cancer coming back by 40% to 50% in postmenopausal women and by 30% to 50% in premenopausal women